Effect of Diallylsulphide Supplementation on Wistar Rats Exposed to Mercuric Chloride
Abstract
Purpose: To evaluate the protective potential of diallylsulphide (DAS) against mercury-induced oxidative stress and antioxidant enzymatic alterations in spleen of rats.
Methods: Rats were randomly divided into 4 groups of 6 rats each and exposed to mercuric chloride (HgCl2) (50 mg/kg, i.p.) and/or diallylsulphide (200 mg/kg/b.w) by gavage. Oxidative stress was evaluated in spleen by antioxidant markers, viz, lipid per oxidation (LPO), superoxide dismutase (SOD), reduced glutathione (GSH), glutathione peroxidase (GPx) and catalase (CAT). Histomorphological changes in the spleen of rats were also compared between groups.
Results: Oral administration of DAS at a concentration of 50 mg/kg daily showed a significant increase in GSH and GPx (p < 0.05), SOD and CAT (p < 0.05), as well as decreased LPO (p < 0.05) level in the spleen of rats as compared with HgCl2 treated rats. Histopathology of spleen also showed that administration of DAS reduced the damage generated by HgCl2 treatment.
Conclusion: The results suggest that DAS may effectively normalize impaired antioxidant status in HgCl2-induced oxidative stress. DAS has a protective effect against lipid peroxidation by scavenging free radicals and is thus capable of ameliorating mercury-induced changes in the spleen of adult Wistar rats.
Keywords: Diallylsulphide, Metal toxicity, Antioxidants, Spleen, Mercury
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.